Study of plasma concentration of Imatinib in Chinese patients with gastrointestinal stromal tumor
Phase of Trial: Phase IV
Latest Information Update: 03 May 2017
Price : $35 *
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Pharmacokinetics; Therapeutic Use
- 30 Apr 2017 Status changed from not yet recruiting to completed.
- 22 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
- 22 Apr 2016 Phase of the study is changed from phase I to phase IV.